| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 15.940 | 10.181 | 14.763 | 40.437 | 14.820 | 34.867 | 46.310 | 12.146 | 25.051 | 20.505 |
| Total Income - EUR | 16.195 | 10.181 | 14.763 | 45.910 | 14.820 | 34.867 | 47.217 | 12.163 | 25.961 | 20.728 |
| Total Expenses - EUR | 12.070 | 11.113 | 13.296 | 37.181 | 17.600 | 29.507 | 32.048 | 20.650 | 13.674 | 29.912 |
| Gross Profit/Loss - EUR | 4.125 | -933 | 1.467 | 8.730 | -2.781 | 5.360 | 15.168 | -8.487 | 12.287 | -9.185 |
| Net Profit/Loss - EUR | 3.646 | -1.054 | 1.320 | 8.270 | -2.987 | 4.895 | 14.753 | -8.607 | 10.405 | -9.891 |
| Employees | 3 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 |
Check the financial reports for the company - Danny Medvet S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 693 | 560 | 444 | 324 | 2.238 |
| Current Assets | 13.043 | 8.815 | 11.665 | 12.972 | 12.652 | 32.405 | 32.602 | 29.971 | 35.653 | 31.133 |
| Inventories | 0 | 0 | 625 | 2.208 | 1.110 | 27 | 54 | 602 | 344 | 54 |
| Receivables | 4.004 | 2.301 | 2.262 | 2.480 | 0 | 6.753 | 21.490 | 28.781 | 28.590 | 20.996 |
| Cash | 9.039 | 6.514 | 8.778 | 8.285 | 11.541 | 25.624 | 11.058 | 587 | 6.719 | 10.084 |
| Shareholders Funds | 5.033 | 3.928 | 5.182 | 8.322 | 5.195 | 9.992 | 24.523 | 15.992 | 24.948 | 14.918 |
| Social Capital | 45 | 45 | 44 | 43 | 63 | 62 | 61 | 61 | 61 | 60 |
| Debts | 8.010 | 4.887 | 6.483 | 4.650 | 7.456 | 23.192 | 8.675 | 14.422 | 11.029 | 18.453 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7500 - 7500" | |||||||||
| CAEN Financial Year |
7500
|
|||||||||
Comments - Danny Medvet S.r.l.